Hypertension in women: Latest findings and clinical implications

Therapeutic Advances in Chronic Disease

Volumn 3, Issue 3, 2012, Pages 137-146

  Gudmundsdottir, Helga ^a   Høieggen, Aud ^a   Stenehjem, Aud ^a   Waldum, Bård ^a   Os, Ingrid ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cardiovascular disease; Hypertension; Women

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LOSARTAN; SEX HORMONE; THIAZIDE DIURETIC AGENT;

ALCOHOL CONSUMPTION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VISCOSITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COUGHING; DISEASE ACTIVITY; GOUT; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPONATREMIA; INCIDENCE; KIDNEY FAILURE; LIFESTYLE MODIFICATION; MOLECULAR PATHOLOGY; MORBIDITY; OBESITY; OXIDATIVE STRESS; PLASMA RENIN ACTIVITY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS; SODIUM RESTRICTION; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

EID: 84868669150     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622312438935     Document Type: Review

References (105)

1. August P. Oparil S. (1999) Hypertension in women. J Clin Endocrinol Metab 84: 1862–1866.
2. Aurigemma G.P. Gaasch W.H. (1995) Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. Cardiology 86: 310–317.
3. Barker D.J. Winter P.D. Osmond C. Margetts B. Simmonds S.J. (1989) Weight in infancy and death from ischaemic heart disease. Lancet 2: 577–580.
4. Bech-Hanssen O. Wallentin I. Houltz E. Beckman S.M. Larsson S. Caidahl K. (1999) Gender differences in patients with severe aortic stenosis: impact on preoperative left ventricular geometry and function, as well as early postoperative morbidity and mortality. Eur J Cardio-Thoracic Surg 15: 24–30.
5. Bella J.N. Palmieri V. Kitzman D.W. Liu J.E. Oberman A. Hunt S.C. et al. (2002) Gender difference in diastolic function in hypertension (the HyperGEN study). Am J Cardiol 89: 1052–1056.
6. Bui A.L. Horwich T.B. Fonarow G.C. (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8: 30–41.
7. Bulatov V.A. Stenehjem A. Os I. (2001) Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension. J Hypertension 19: 1473–1478.
8. Burt V.L. Whelton P. Roccella E.J. Brown C. Cutler J.A. Higgins M. et al. (1995) Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 25: 305–313.
9. Carroll J.D. Carroll E.P. Feldman T. Ward D.M. Lang R.M. McGaughey D. et al. (1992) Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86: 1099–1107.
10. Cederholm J. Gudbjornsdottir S. Eliasson B. Zethelius B. Eeg-Olofsson K. Nilsson P.M. (2010) Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register. J Hypertens 28: 2026–2035.
11. Chapman N. Neal B. (2001) Prospectively designed overviews of recent trials comparing antihypertensive regimens based on different drug classes. Curr Hypertens Rep 3: 340–349.
12. Cushman W.C. Evans G.W. Byington R.P. Goff D.C. Jr Grimm R.H. Jr Cutler J.A. et al. 2010. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362: 1575–1585.
13. de Simone G. Devereux R.B. Chien S. Alderman M.H. Atlas S.A. Laragh J.H. (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81: 107–117.
14. de Simone G. Devereux R.B. Roman M.J. Alderman M.H. Laragh J.H. (1994) Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23: 600–606.
15. de Simone G. Devereux R.B. Roman M.J. Ganau A. Chien S. Alderman M.H. et al. (1991) Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol 68: 1704–1708.
16. Dubey R.K. Oparil S. Imthurn B. Jackson E.K. (2002) Sex hormones and hypertension. Cardiovasc Res 53: 688–708.
17. Duerrschmidt N. Wippich N. Goettsch W. Broemme H.J. Morawietz H. (2000) Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun 269: 713–717.
18. Eriksson J.G. (2005) The fetal origins hypothesis–10 years on. BMJ 330: 1096–1097.
19. Eriksson J.G. Forsen T. Tuomilehto J. Osmond C. Barker D.J. (2001) Early growth and coronary heart disease in later life: longitudinal study. BMJ 322: 949–953.
20. European Society of Hypertension and European Society of Cardiology (2003) 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011–1053.
21. Ferdinand K.C. Ferdinand D.P. (2008) Race-based therapy for hypertension: possible benefits and potential pitfalls. Expert Rev Cardiovasc Ther 6: 1357–1366.
22. Fields L.E. Burt V.L. Cutler J.A. Hughes J. Roccella E.J. Sorlie P. 2004. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44: 398–404.
23. Fischer M. Baessler A. Schunkert H. (2002) Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53: 672–677.
24. Ford E.S. Ajani U.A. Croft J.B. Critchley J.A. Labarthe D.R. Kottke T.E. et al. (2007) Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 356: 2388–2398.
25. Fortepiani L.A. Zhang H. Racusen L. Roberts L.J. Reckelhoff J.F. (2003) Characterization of an animal model of postmenopausal hypertension in spontaneously hypertensive rats. Hypertension 41: 640–645.
26. Fossum E. Hoieggen A. Moan A. Nordby G. Velund T.L. Kjeldsen S.E. (1997) Whole blood viscosity, blood pressure and cardiovascular risk factors in healthy blood donors. Blood Press 6: 161–165.
27. Frankel S. Elwood P. Sweetnam P. Yarnell J. Smith G.D. (1996) Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet 348: 1478–1480.
28. Gerdts E. Zabalgoitia M. Bjornstad H. Svendsen T.L. Devereux R.B. (2001) Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol 87: 980–983.
29. Gholizadeh L. Davidson P. (2008) More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int 29: 3–22.
30. Grimm R.H. Jr Grandits G.A. Prineas R.J. McDonald R.H. Lewis C.E. Flack J.M. et al. (1997) Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 29: 8–14.
31. Gu Q. Burt V.L. Paulose-Ram R. Dillon C.F. (2008) Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens 21: 789–798.
32. Hertz R.P. Unger A.N. Cornell J.A. Saunders E. (2005) Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 165: 2098–2104.
33. Himmelmann A. Svensson A. Hansson L. (1994) Influence of sex on blood pressure and left ventricular mass in adolescents: the Hypertension in Pregnancy Offspring Study. J Human Hypertens 8: 485–490.
34. Hoieggen A. Fossum E. Nesbitt S.D. Palmieri V. Kjeldsen S.E. (2000) Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica. Blood Press 9: 83–90.
35. Janssen I. Powell L.H. Kazlauskaite R. Dugan S.A. (2010) Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. Obesity (Silver Spring) 18: 604–610.
36. Jarvie J.L. Foody J.M. (2010) Recognizing and improving health care disparities in the prevention of cardiovascular disease in women. Curr Cardiol Rep 12: 488–496.
37. Jones C.A. Nagpal S. (2001) An update: women, hypertension and therapeutic efficacy. Can J Cardiol 17: 1283–1289.
38. Jonsdottir L.S. Arngrimsson R. Geirsson R.T. Sigvaldason H. Sigfusson N. (1995) Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 74: 772–776.
39. Journath G. Hellenius M.L. Manhem K. Kjellgren K.I. Nilsson P.M. (2008) Association of physician's sex with risk factor control in treated hypertensive patients from Swedish primary healthcare. J Hypertens 26: 2050–2056.
40. Kjeldsen S.E. Hedner T. Syvertsen J.O. Lund-Johansen P. Hansson L. Lanke J. et al. (2002) Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study. J Hypertens 20: 1231–1237.
41. Kjeldsen S.E. Warnold I. Hansson L. (2000) Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study. J Gend Specif Med 3 (8): 35–38.
42. Klungel O.H. Paes A.H. de Boer A. Kuyvenhoven M.M. Seidell J.C. Bakker A. (2000) Sex differences in the medication choice for hypertension in general practice. A study with written case simulations. Pharm World Sci 22: 140–146.
43. Koren M.J. Devereux R.B. Casale P.N. Savage D.D. Laragh J.H. (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345–352.
44. Kotchen J.M. McKean H.E. Kotchen T.A. (1982) Blood pressure trends with aging. Hypertension 4(5 Pt 2): III128–III134.
45. Lande K. Kjeldsen S.E. Os I. Westheim A. Hjermann I. Eide I. et al. (1988) Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens 6: 219–225.
46. Lande K. Os I. Kjeldsen S.E. Westheim A. Hjermann I. Eide I. et al. (1987) Increased platelet size and release reaction in essential hypertension. J Hypertens 5: 401–406.
47. Legget M.E. Kuusisto J. Healy N.L. Fujioka M. Schwaegler R.G. Otto C.M. (1996) Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J 131: 94–100.
48. Leon D.A. Lithell H.O. Vagero D. Koupilova I. Mohsen R. Berglund L. et al. (1998) Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915–29. BMJ 317: 241–245.
49. Letcher R.L. Chien S. Pickering T.G. Sealey J.E. Laragh J.H. (1981) Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med 70: 1195–1202.
50. Levy D. Larson M.G. Vasan R.S. Kannel W.B. Ho K.K. (1996) The progression from hypertension to congestive heart failure. JAMA 275: 1557–1562.
51. Lewis C.E. (1996) Characteristics and treatment of hypertension in women: a review of the literature. Am J Med Sci 311: 193–199.
52. Lewis C.E. Grandits A. Flack J. McDonald R. Elmer P.J. (1996) Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. Arch Intern Med 156: 377–385.
53. Lloyd-Jones D. Adams R.J. Brown T.M. Carnethon M. Dai S. de Simone G. et al. (2010) Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 121 (7): e46–e215.
54. Lloyd-Jones D.M. Larson M.G. Leip E.P. Beiser A. D'Agostino R.B. Kannel W.B. et al. (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106: 3068–3072.
55. Maas A.H. van der Schouw Y.T. Regitz-Zagrosek V. Swahn E. Appelman Y.E. Pasterkamp G. et al. (2011) Red alert for Women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J 32: 1362–1368.
56. Mancia G. De Backer G. Dominiczak A. Cifkova R. Fagard R. Germano G. et al. (2007) Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105–1187.
57. Mancia G. Laurent S. Agabiti-Rosei E. Ambrosioni E. Burnier M. Caulfield M.J. et al. (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 18: 308–347.
58. Mansia G. De Backer G. Dominiczak A. Cifkova R. Fagard R. Germano G. et al. (2007) ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 16: 135–232.
59. Messerli F.H. Williams B. Ritz E. (2007) Essential hypertension. Lancet 370: 591–603.
60. Miller J.A. Anacta L.A. Cattran D.C. (1999) Impact of gender on the renal response to angiotensin II. Kidney Int 55: 278–285.
61. Mimran A. Ribstein J. DuCailar G. (1994) Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 23: 1018–1021.
62. Mortensen L.H. Pawloski C.M. Kanagy N.L. Fink G.D. (1990) Chronic hypertension produced by infusion of endothelin in rats. Hypertension 15: 729–733.
63. Mosca L. Appel L.J. Benjamin E.J. Berra K. Chandra-Strobos N. Fabunmi R.P. et al. (2004) Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109: 672–693.
64. Mosca L. Benjamin E.J. Berra K. Bezanson J.L. Dolor R.J. Lloyd-Jones D.M. et al. (2011) Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American Heart Association. Circulation 123: 1243–1262.
65. Mosterd A. Hoes A.W. de Bruyne M.C. Deckers J.W. Linker D.T. Hofman A. et al. (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20: 447–455.
66. Mundal H.H. Nordby G. Lande K. Gjesdal K. Kjeldsen S.E. Os I. (1993) Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women. Scand J Clin Lab Invest 53: 585–591.
67. Neaton J.D. Grimm R.H. Jr Prineas R.J. Stamler J. Grandits G.A. Elmer P.J. et al. (1993) Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 270: 713–724.
68. Nestel P.J. Clifton P.M. Noakes M. McArthur R. Howe P.R. (1993) Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist: hip ratio. J Hypertens 11: 1387–1394.
69. Nilsson P.M. Li X. Sundquist J. Sundquist K. (2009) Maternal cardiovascular disease risk in relation to the number of offspring born small for gestational age: national, multi-generational study of 2.7 million births. Acta Paediatrica 98: 985–989.
70. Nordby G. Os I. Kjeldsen S.E. Eide I. (1992) Mild essential hypertension in nonobese premenopausal women is characterized by low renin. Am J Hypertens 5: 579–584.
71. Nuzzo A. Rossi R. Modena M.G. (2010) Hypertension alone or related to the metabolic syndrome in postmenopausal women. Expert Rev Cardiovasc Ther 8: 1541–1548.
72. O'Donnell C.J. Lindpaintner K. Larson M.G. Rao V.S. Ordovas J.M. Schaefer E.J. et al. (1998) Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97: 1766–1772.
73. Olsen H. Klemetsrud T. Stokke H.P. Tretli S. Westheim A. (1999) Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Press 8: 94–101.
74. Oparil S. (2006) Women and hypertension: what did we learn from the Women's Health Initiative? Cardiol Rev 14: 267–275.
75. Oparil S. (2009) Hormone therapy of premature ovarian failure: the case for “natural” estrogen. Hypertension 53: 745–746.
76. Oparil S. Zaman M.A. Calhoun D.A. (2003) Pathogenesis of hypertension. Ann Intern Med 139: 761–776.
77. Os I. Bratland B. Dahlof B. Gisholt K. Syvertsen J.O. Tretli S. (1991) Lisinopril and nifedipine in essential hypertension: a Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients. J Hypertens Suppl 9 (6): S382–S383.
78. Os I. Bratland B. Dahlof B. Gisholt K. Syvertsen J.O. Tretli S. 1994. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 7: 1012–1015.
79. Os I. Franco V. Kjeldsen S.E. Manhem K. Devereux R.B. Gerdts E. et al. (2008) Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 51: 1103–1108.
80. Os I. Kjeldsen S.E. Nordby G. Eide I. Lande K. Hjermann I. et al. (1993) Sex differences in essential hypertension. J Intern Med 233: 13–19.
81. Os I. Oparil S. Gerdts E. Hoieggen A. (2004) Essential hypertension in women. Blood Press 13: 272–278.
82. Psaty B.M. Smith N.L. Siscovick D.S. Koepsell T.D. Weiss N.S. Heckbert S.R. et al. (1997) Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 277: 739–745.
83. Rahman M. Douglas J.G. Wright J.T. Jr (1997) Pathophysiology and treatment implications of hypertension in the African-American population. Endocrinol Metab Clin North Am 26: 125–144.
84. Rappelli A. (2002) Hypertension and obesity after the menopause. J Hypertens Suppl 20 (2): S26–S28.
85. Reckelhoff J.F. (2001) Gender differences in the regulation of blood pressure. Hypertension 37: 1199–1208.
86. Rich-Edwards J.W. Stampfer M.J. Manson J.E. Rosner B. Hankinson S.E. Colditz G.A. et al. (1997) Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 315: 396–400.
87. Roger V.L. Go A.S. Lloyd-Jones D.M. Adams R.J. Berry J.D. Brown T.M. et al. (2011) Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123: e18–e209.
88. Romundstad S. Holmen J. Hallan H. Kvenild K. Ellekjaer H. (2003) Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trondelag Health Study (HUNT), Norway. Circulation 108: 2783–2789.
89. Ross A.E. Flaa A. Hoieggen A. Reims H. Eide I.K. Kjeldsen S.E. (2001) Gender specific sympathetic and hemorrheological responses to mental stress in healthy young subjects. Scand Cardiovasc J 35: 307–312.
90. Rossouw J.E. Anderson G.L. Prentice R.L. LaCroix A.Z. Kooperberg C. Stefanick M.L. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333.
91. Sacks F.M. Svetkey L.P. Vollmer W.M. Appel L.J. Bray G.A. Harsha D. et al. (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344: 3–10.
92. Schunkert H. Danser A.H. Hense H.W. Derkx F.H. Kurzinger S. Riegger G.A. (1997) Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95: 39–45.
93. Sethi A.A. Nordestgaard B.G. Gronholdt M.L. Steffensen R. Jensen G. Tybjaerg-Hansen A. (2003) Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 41: 1202–1211.
94. Sevre K. Lefrandt J.D. Nordby G. Os I. Mulder M. Gans R.O. et al. (2001) Autonomic function in hypertensive and normotensive subjects: the importance of gender. Hypertension 37: 1351–1356.
95. Singh J.P. Larson M.G. Tsuji H. Evans J.C. O'Donnell C.J. Levy D. (1998) Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 32: 293–297.
96. Smith S.C. Jr Allen J. Blair S.N. Bonow R.O. Brass L.M. Fonarow G.C. et al. (2006) AHA / ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113: 2363–2372.
97. Tan Y.Y. Gast G.C. van der Schouw Y.T. (2010) Gender differences in risk factors for coronary heart disease. Maturitas 65: 149–160.
98. Vikse B.E. Irgens L.M. Leivestad T. Skjaerven R. Iversen B.M. (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359: 800–809.
99. Wallen W.J. Cserti C. Belanger M.P. Wittnich C. (2000) Gender-differences in myocardial adaptation to afterload in normotensive and hypertensive rats. Hypertension 36: 774–779.
100. Wassertheil-Smoller S. Anderson G. Psaty B.M. Black H.R. Manson J. Wong N. et al. (2000) Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension 36: 780–789.
101. Wassertheil-Smoller S. Blaufox M.D. Oberman A. Davis B.R. Swencionis C. Knerr M.O. et al. (1991) Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med 114: 613–620.
102. Wilsgaard T. Schirmer H. Arnesen E. (2000) Impact of body weight on blood pressure with a focus on sex differences: the Tromso Study, 1986–1995. Arch Intern Med 160: 2847–2853.
103. Wilson P.W. D'Agostino R.B. Sullivan L. Parise H. Kannel W.B. (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162: 1867–1872.
104. Wing L.M. Reid C.M. Ryan P. Beilin L.J. Brown M.A. Jennings G.L. et al. (2003) A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348: 583–592.
105. Yang X.P. Reckelhoff J.F. (2011) Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens 20: 133–138.